Research is often lauded for finding life-saving treatments for diseases like cancer or diabetes. But consider the impact of preventing such illnesses from developing in the first place. It’s hard to describe the value of stopping illness or injury from happening. Yet that’s the goal of research on preventive care.
Most Kaiser Permanente Washington scientists study prevention, whether their work focuses on promoting health by influencing individual behavior, building sound prevention services into everyday clinical care, designing smart health coverage, or all three. By conducting their research at Kaiser Permanente Washington—which combines care and coverage—our researchers have access to data from a large, stable population over time, allowing them to discover which approaches to prevention work best.
Examples include research in areas such as:
A team of researchers at Kaiser Permanente Washington Health Research Institute (KPWHRI) produces reviews of scientific evidence that policymakers at the Centers for Medicare & Medicaid Services and the U.S. Preventive Services Task Force and others use in health care decision-making. We do this work as part of the Kaiser Permanente Research Affiliates Evidence-based Practice Center, one of 13 centers nationwide that are sponsored by the federal Agency for Healthcare Research and Quality.
We’re improving the safety and effectiveness of vaccines through clinical trials, and we’re monitoring how well each year’s new flu vaccines are working. In addition, we’re studying ways to better inform parents about the benefits and potential harms of childhood vaccines, to improve their uptake.
We’re working on several fronts to help ensure the safety of prescription drugs and other medical treatments. For example, we play a leading role in the Food and Drug Administration’s Sentinel program to monitor the safety of medical products through routinely collected electronic health care data. We’re exploring ways to improve the safety of prescribing opioid pain medications. And we often study the safety of drugs commonly used to prevent chronic conditions like heart disease, cancer, and depression.
Prevention also includes screening to detect disease before symptoms appear, to identify and treat disease at an earlier stage. Our research is improving the effectiveness of cancer screening programs so people get the appropriate tests when needed based on their particular risks. Our research is also aimed at improving clinical screening for behavioral risks such as smoking, suicidal thoughts, alcohol use disorders, and poor eating and exercise habits.
Our research in areas such as smoking cessation, healthy diet, and chronic illness care finds new ways to encourage individuals to adopt and maintain healthier lifestyles. At the same time, we’re exploring ways to reach large populations through the use of phone-based programs, websites, and mobile technologies.
Dunn J, Henrikson NB, Morrison CC, Blasi PR, Nguyen M, Lin JS. Screening for adolescent idiopathic scoliosis: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018 Jan 9;319(2):173-187. doi: 10.1001/jama.2017.11669. PubMed
Kemper AR, Krist AH, Tseng CW, Gillman MW, Mabry-Hernandez IR, Silverstein M, Chou R, Lozano P, Calonge BN, Wolff TA, Grossman DC. Challenges in developing U.S. Preventive Services Task Force child health recommendations. Am J Prev Med. 2018 Jan;54(1S1):S63-S69. doi: 10.1016/j.amepre.2017.08.023. PubMed
Ngo-Metzger Q, Moyer V, Grossman D, Ebell M, Woo M, Miller T, Brummer T, Chowdhury J, Kato E, Siu A, Phillips W, Davidson K, Phipps M, Bibbins-Domingo K. Conflicts of interest in clinical guidelines: update of U.S. Preventive Services Task Force policies and procedures. Am J Prev Med. 2018 Jan;54(1S1):S70-S80. doi: 10.1016/j.amepre.2017.06.034.Am J Prev Med. 2018 Jan;54(1S1):S70-S80. doi: 10.1016/j.amepre.2017.06.034. PubMed
Krist AH, Wolff TA, Jonas DE, Harris RP, LeFevre ML, Kemper AR, Mangione CM, Tseng CW, Grossman DC. Update on the methods of the U.S. Preventive Services Task Force: methods for understanding certainty and net benefit when making recommendations. Am J Prev Med. 2018 Jan;54(1S1):S11-S18. doi: 10.1016/j.amepre.2017.09.011. PubMed
Lin JS, Evans CV, Grossman DC, Tseng CW, Krist AH. Framework for using risk stratification to improve clinical preventive service guidelines. Am J Prev Med. 2018;54(1S1):S26-S37. doi: 10.1016/j.amepre.2017.07.023. PubMed
![]() Paula Lozano, MD, MPHSenior Investigator |
![]() Katharine A. Bradley, MD, MPHSenior Investigator |
![]() Jessica Chubak, PhDSenior Investigator |
![]() Dori E. Rosenberg, PhD, MPHAssociate Investigator |
![]() Karen Wernli, PhDSenior Investigator |
![]() Erin J. Bowles, MPHManager, Collaborative Science |
![]() Nora Henrikson, PhD, MPHAssociate Investigator |
![]() Aruna Kamineni, PhD, MPHAssistant Investigator |
![]() Melissa L. Anderson, MSPrincipal Collaborative Biostatistician |
![]() Paula R. Blasi, MPHCollaborative Scientist |
![]() Joseph E. Glass, PhD, MSWAssociate Investigator |
![]() Julie E. Richards, PhD, MPHSenior Collaborative Scientist |
![]() Yu-Ru Su, PhDAssistant Biostatistics Investigator |
![]() Annie Hoopes, MD, MPHActing Assistant Investigator |
![]() Pamela A. Shaw, PhD, MSSenior Biostatistics Investigator |
![]() Claire Allen, MPHManager, Collaborative Science |
![]() Nicole M. Gatto, PhD, MPHPrincipal Collaborative Scientist |
![]() Kelsey Stefanik-Guizlo, MPHCollaborative Scientist |
![]() Theresa E. Matson, PhD, MPHCollaborative Scientist |
![]() Meagan C. Brown, PhD, MPHCollaborative Scientist |